Search research articles
Contact Us
Filters
Showing results (71-80 of 85) with videos related to
Page
of 9
Sort By:
Journal of Neurosurgery
|
October 25, 2023
Endoscopic endonasal repair of encephaloceles of the lateral sphenoid sinus: multiinstitution confirmation of a new classification
Umberto Tosi, Christina Jackson, Glen D'Souza, et al.
Oncoimmunology
|
April 9, 2024
CCR2 and CCR5 co-inhibition modulates immunosuppressive myeloid milieu in glioma and synergizes with anti-PD-1 therapy
Ayush Pant, Brandon Hwa-Lin Bergsneider, Siddhartha Srivastava, et al.
Journal of Neurosurgery
|
August 13, 2021
Synergy between glutamate modulation and anti-programmed cell death protein 1 immunotherapy for glioblastoma
Ravi Medikonda, John Choi, Ayush Pant, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 2, 2026
Hypofractionated Proton Reirradiation for Recurrent Glioblastoma: Clinical and Dosimetric Outcomes from a Large Single Institution Series
Lauren Linkowski, Ian Messing, Melanie Berger, et al.
JCO Precision Oncology
|
September 4, 2025
Next-Generation Sequencing of Intraoperatively Acquired Cerebrospinal Fluid and Matched Tumor Tissue in Patients Undergoing Surgical Resection for Glioblastoma
Erica L Carpenter, Jacob E Till, Dominique Ballinger, et al.
Journal of Neuro-Oncology
|
April 25, 2026
Clinical, molecular, and immunologic determinants of survival in WHO-defined IDH-wildtype glioblastoma treated with radiotherapy: a large real-world cohort study
Cole Friedes, Melanie Berger, Lauren Linkowski, et al.
Journal for Immunotherapy of Cancer
|
May 19, 2016
Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma
Mira A Patel, Jennifer E Kim, Debebe Theodros, et al.
Journal for Immunotherapy of Cancer
|
November 9, 2016
Erratum to: Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma
Mira A Patel, Jennifer E Kim, Debebe Theodros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 14, 2018
T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
Karolina Woroniecka, Pakawat Chongsathidkiet, Kristen Rhodin, et al.
Science (New York, N.Y.)
|
January 17, 2025
Distinct myeloid-derived suppressor cell populations in human glioblastoma
Christina Jackson, Christopher Cherry, Sadhana Bom, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 85) with videos related to
Sort By:
Page
of 9
Journal of Neurosurgery
|
October 25, 2023
Endoscopic endonasal repair of encephaloceles of the lateral sphenoid sinus: multiinstitution confirmation of a new classification
Umberto Tosi, Christina Jackson, Glen D'Souza, et al.
Oncoimmunology
|
April 9, 2024
CCR2 and CCR5 co-inhibition modulates immunosuppressive myeloid milieu in glioma and synergizes with anti-PD-1 therapy
Ayush Pant, Brandon Hwa-Lin Bergsneider, Siddhartha Srivastava, et al.
Journal of Neurosurgery
|
August 13, 2021
Synergy between glutamate modulation and anti-programmed cell death protein 1 immunotherapy for glioblastoma
Ravi Medikonda, John Choi, Ayush Pant, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 2, 2026
Hypofractionated Proton Reirradiation for Recurrent Glioblastoma: Clinical and Dosimetric Outcomes from a Large Single Institution Series
Lauren Linkowski, Ian Messing, Melanie Berger, et al.
JCO Precision Oncology
|
September 4, 2025
Next-Generation Sequencing of Intraoperatively Acquired Cerebrospinal Fluid and Matched Tumor Tissue in Patients Undergoing Surgical Resection for Glioblastoma
Erica L Carpenter, Jacob E Till, Dominique Ballinger, et al.
Journal of Neuro-Oncology
|
April 25, 2026
Clinical, molecular, and immunologic determinants of survival in WHO-defined IDH-wildtype glioblastoma treated with radiotherapy: a large real-world cohort study
Cole Friedes, Melanie Berger, Lauren Linkowski, et al.
Journal for Immunotherapy of Cancer
|
May 19, 2016
Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma
Mira A Patel, Jennifer E Kim, Debebe Theodros, et al.
Journal for Immunotherapy of Cancer
|
November 9, 2016
Erratum to: Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma
Mira A Patel, Jennifer E Kim, Debebe Theodros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 14, 2018
T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
Karolina Woroniecka, Pakawat Chongsathidkiet, Kristen Rhodin, et al.
Science (New York, N.Y.)
|
January 17, 2025
Distinct myeloid-derived suppressor cell populations in human glioblastoma
Christina Jackson, Christopher Cherry, Sadhana Bom, et al.
Page
of 9